The volatile organic compounds (VOCs) generated by the skin in response to psychological stress.
Inventiva stock sinks 20% after serious adverse event in NASH trial leads to enrollment pause
Inventiva has paused screening and entering new patients in its Phase III NASH study for lanifibranor after a possibly treatment-related adverse event. The company said